Lack of Smaller M&A Raises Questions as Megadeals Abound

The video discusses the impact of market volatility on CEO confidence and deal-making, highlighting a decline in smaller deals due to geopolitical issues. However, mega deals have thrived under these conditions, particularly in the healthcare sector, with examples like the Bristol Myers and Celgene merger. The video also explores the challenges faced by bankers due to regulatory hurdles and increased investor scrutiny, driven by the rise of passive investing strategies.

What challenges are bankers facing with large deals this year?

Why are traditional long-only investors starting to challenge big deals?